These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 36563966)

  • 41. Effects of ghrelin on the electrical activities of substantia nigra dopaminergic neurons treated with MPP
    Chang X; Ma Z; Shi L; Xie J
    Neurochem Int; 2020 Sep; 138():104780. PubMed ID: 32569790
    [TBL] [Abstract][Full Text] [Related]  

  • 42. HOTAIR drives autophagy in midbrain dopaminergic neurons in the substantia nigra compacta in a mouse model of Parkinson's disease by elevating NPTX2
    Lang Y; Li Y; Yu H; Lin L; Chen X; Wang S; Zhang H
    Aging (Albany NY); 2020 May; 12(9):7660-7678. PubMed ID: 32396526
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Neuronal inhibition and synaptic plasticity of basal ganglia neurons in Parkinson's disease.
    Milosevic L; Kalia SK; Hodaie M; Lozano AM; Fasano A; Popovic MR; Hutchison WD
    Brain; 2018 Jan; 141(1):177-190. PubMed ID: 29236966
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lower Affinity of Isradipine for L-Type Ca
    Ortner NJ; Bock G; Dougalis A; Kharitonova M; Duda J; Hess S; Tuluc P; Pomberger T; Stefanova N; Pitterl F; Ciossek T; Oberacher H; Draheim HJ; Kloppenburg P; Liss B; Striessnig J
    J Neurosci; 2017 Jul; 37(28):6761-6777. PubMed ID: 28592699
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The spatiotemporal changes in dopamine, neuromelanin and iron characterizing Parkinson's disease.
    Biondetti E; Santin MD; Valabrègue R; Mangone G; Gaurav R; Pyatigorskaya N; Hutchison M; Yahia-Cherif L; Villain N; Habert MO; Arnulf I; Leu-Semenescu S; Dodet P; Vila M; Corvol JC; Vidailhet M; Lehéricy S
    Brain; 2021 Nov; 144(10):3114-3125. PubMed ID: 33978742
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Firing pattern modulation through SK channel current increase underlies neuronal survival in an organotypic slice model of Parkinson's disease.
    Wang Y; Qu L; Wang XL; Gao L; Li ZZ; Gao GD; Yang Q
    Mol Neurobiol; 2015 Feb; 51(1):424-36. PubMed ID: 24841382
    [TBL] [Abstract][Full Text] [Related]  

  • 47. GABAergic control of substantia nigra dopaminergic neurons.
    Tepper JM; Lee CR
    Prog Brain Res; 2007; 160():189-208. PubMed ID: 17499115
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Colchicine protects dopaminergic neurons in a rat model of Parkinson's disease.
    Salama M; Ellaithy A; Helmy B; El-Gamal M; Tantawy D; Mohamed M; Sheashaa H; Sobh M; Arias-Carrión O
    CNS Neurol Disord Drug Targets; 2012 Nov; 11(7):836-43. PubMed ID: 23198691
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immune Response Modifications in the Genetic Forms of Parkinson's Disease: What Do We Know?
    Magistrelli L; Contaldi E; Vignaroli F; Gallo S; Colombatto F; Cantello R; Comi C
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408836
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Subthalamic nucleus lesions reduce low frequency oscillatory firing of substantia nigra pars reticulata neurons in a rat model of Parkinson's disease.
    Tseng KY; Kasanetz F; Kargieman L; Pazo JH; Murer MG; Riquelme LA
    Brain Res; 2001 Jun; 904(1):93-103. PubMed ID: 11516415
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison between the pharmacology of dopamine receptors mediating the inhibition of cell firing in rat brain slices through the substantia nigra pars compacta and ventral tegmental area.
    Bowery B; Rothwell LA; Seabrook GR
    Br J Pharmacol; 1994 Jul; 112(3):873-80. PubMed ID: 7921615
    [TBL] [Abstract][Full Text] [Related]  

  • 52. 7 Tesla magnetic resonance imaging: a closer look at substantia nigra anatomy in Parkinson's disease.
    Lehéricy S; Bardinet E; Poupon C; Vidailhet M; François C
    Mov Disord; 2014 Nov; 29(13):1574-81. PubMed ID: 25308960
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Depopulation of dense α-synuclein aggregates is associated with rescue of dopamine neuron dysfunction and death in a new Parkinson's disease model.
    Wegrzynowicz M; Bar-On D; Calo' L; Anichtchik O; Iovino M; Xia J; Ryazanov S; Leonov A; Giese A; Dalley JW; Griesinger C; Ashery U; Spillantini MG
    Acta Neuropathol; 2019 Oct; 138(4):575-595. PubMed ID: 31165254
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Generation of a Novel Mouse Model of Parkinson's Disease via Targeted Knockdown of Glutamate Transporter GLT-1 in the Substantia Nigra.
    Zhang Y; Meng X; Jiao Z; Liu Y; Zhang X; Qu S
    ACS Chem Neurosci; 2020 Feb; 11(3):406-417. PubMed ID: 31909584
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dopaminergic and non-dopaminergic neurons in substantia nigra: differential response to bromocriptine.
    Scarnati E; Forchetti C; Ciancarelli G; Pacitti C; Agnoli A
    J Neural Transm; 1980; 48(4):297-303. PubMed ID: 7420076
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Neuromelanin magnetic resonance imaging of locus ceruleus and substantia nigra in Parkinson's disease.
    Sasaki M; Shibata E; Tohyama K; Takahashi J; Otsuka K; Tsuchiya K; Takahashi S; Ehara S; Terayama Y; Sakai A
    Neuroreport; 2006 Jul; 17(11):1215-8. PubMed ID: 16837857
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Aberrant Tonic Inhibition of Dopaminergic Neuronal Activity Causes Motor Symptoms in Animal Models of Parkinson's Disease.
    Heo JY; Nam MH; Yoon HH; Kim J; Hwang YJ; Won W; Woo DH; Lee JA; Park HJ; Jo S; Lee MJ; Kim S; Shim JE; Jang DP; Kim KI; Huh SH; Jeong JY; Kowall NW; Lee J; Im H; Park JH; Jang BK; Park KD; Lee HJ; Shin H; Cho IJ; Hwang EM; Kim Y; Kim HY; Oh SJ; Lee SE; Paek SH; Yoon JH; Jin BK; Kweon GR; Shim I; Hwang O; Ryu H; Jeon SR; Lee CJ
    Curr Biol; 2020 Jan; 30(2):276-291.e9. PubMed ID: 31928877
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Somatic copy number gains of α-synuclein (SNCA) in Parkinson's disease and multiple system atrophy brains.
    Mokretar K; Pease D; Taanman JW; Soenmez A; Ejaz A; Lashley T; Ling H; Gentleman S; Houlden H; Holton JL; Schapira AHV; Nacheva E; Proukakis C
    Brain; 2018 Aug; 141(8):2419-2431. PubMed ID: 29917054
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Characterization of Age-dependent Behavior Deficits in the PGC-1α Knockout Mouse, in Relevance to the Parkinson's Disease Model.
    Sun Z; Ma X; Yang H; Chen S; He S; Sun R; Lu H; Zhang J
    Neuroscience; 2020 Aug; 440():39-47. PubMed ID: 32439544
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dopaminergic D2 receptor is a key player in the substantia nigra pars compacta neuronal activation mediated by REM sleep deprivation.
    Proença MB; Dombrowski PA; Da Cunha C; Fischer L; Ferraz AC; Lima MM
    Neuropharmacology; 2014 Jan; 76 Pt A():118-26. PubMed ID: 24012539
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.